KD Logo

Tag: NASDAQ:SLNO

Analysts Viewpoint

Stifel’s latest rating for SLNO stock

Soleno Therapeutics Inc’s filing revealed that its Rule 144 Affiliate Abingworth Bioventures VII LP acquired Company’s shares for reported $51.42